[
Arrow, K. J. 1963. “Uncertainty and the Welfare Economics of Medical Care.” American Economic Review 53(5), 941 – 973.
]Search in Google Scholar
[
Banta, D. and E. Jonsson. 2009. “History of HTA: Introduction.” International Journal of Technology Assessment in Health Care 25(S1), 1 – 6.
]Search in Google Scholar
[
Bodenheimer, T. 2005. “High and Rising Health Care Costs. Part 2: Technologic Innovation.” Annals of Internal Medicine 142(11), 932 – 937.
]Search in Google Scholar
[
Ciani, O., P. Armeni, P. R. Boscolo, M. Cavazza, C. Jommi and R. Tarricone. 2016. “De Innovatione: The Concept of Innovation for Medical Technologies and its Implications for Healthcare Policy-Making.” Health Policy and Technology 5(1), 47 – 64.
]Search in Google Scholar
[
Cookson, R. and J. Hutton. 2003. “Regulating the Economic Evaluation of Pharmaceuticals and Medical Devices: A European Perspective.” Health Policy 63(2), 167 – 178.
]Search in Google Scholar
[
Council of the European Communities. 1993. Council Directive of 14 June 1993 concerning medical devices. 93 / 42 / EEC. 2007.
]Search in Google Scholar
[
Drummond, M., A. Griffin and R. Tarricone. 2009. “Economic Evaluation for Devices and Drugs, Same or Different ?” Value in Health 12(4), 402 – 404.
]Search in Google Scholar
[
EUnetHTA Joint Action 2: Work Package 8.2016. HTA Core Model ® version 3.0 (Pdf): EUnetHTA. Available at www.htacoremodel.info/BrowseModel.aspx (last accessed 20 September 2020).
]Search in Google Scholar
[
Feldstein, P. 1993. Health Care Economics. Albany: Delmar Publishers.
]Search in Google Scholar
[
Friedberg, M., B. Saffran, T. J. Stinson, W. Nelson and C. L. Bennett. 1999. “Evaluation of Conflict of Interest in Economic Analyses of New Drugs used in Oncology.” Jama 282(15), 1453 – 1457.
]Search in Google Scholar
[
Gajdošová, E. 2018. “New Technologies as One of Key Drivers of Healthcare Spending Growth in the Czech Republic.” In Petra Dvořáková (ed.). Current Trends in Public Sector Research. Brno: Masarykova univerzita, 244 – 251.
]Search in Google Scholar
[
Garrido, M. V., A. Gerhardus, J. A. Røttingen and R. Busse. 2010. “Developing Health Technology Assessment to Address Health Care System Needs.” Health Policy 94(3), 196 – 202.
]Search in Google Scholar
[
Garrido, M. V., F. B. Kristensen, C. P. Nielsen and R. Busse. 2008. Health Technology Policy-Making in Europe: Current Status, Challenges and Potential. United KingdomPlace: World Health Organization.
]Search in Google Scholar
[
Goodman, C. 2004. HTA 101: Introduction to Health Technology Assessment. USA: US National Library of Medicine, National Institutes of Health, National Information Center on Health Services Research and Health Care Technology (NICHSR).
]Search in Google Scholar
[
Government of the Czech Republic 2018.
]Search in Google Scholar
[
Gulácsi, L., A. M. Rotar, M. Niewada, O. Löblová, F. Rencz, G. Petrova and N. S. Klazinga. 2014. “Health Technology Assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria.” European Journal of Health Economics 15(1), 13 – 25.
]Search in Google Scholar
[
Hartz, S. and J. John. 2009. “Public Health Policy Decisions on Medical Innovations: What Role can Early Economic Evaluation Play ?” Health Policy 89(2), 184 – 192.
]Search in Google Scholar
[
Hjelmgren, J., F. Berggren and F. Andersson. 2001. “Health Economic Guidelines: Similarities, Differences and Some Implications.” Value in Health 4(3), 225 – 250.
]Search in Google Scholar
[
Kaló, Z., A. Gheorghe, M. Huic, M. Csanádi and F. B. Kristensen. 2016. “HTA Implementation Roadmap in Central and Eastern European Countries.” Health Economics 25, 179 – 192.
]Search in Google Scholar
[
Kirisits, A. and W. K. Redekop. 2013. “The Economic Evaluation of Medical Devices.” Applied Health Economics and Health Policy 11(1), 15 – 26.
]Search in Google Scholar
[
Lamovsek, N. and M. Klun. 2020. “Efficiency of Medical Laboratories after Quality Standard Introduction: Trend Analysis of Selected EU Countries and Case Study from Slovenia.” Cent. Eur. Pub. Admin. Rev. 18, 143.
]Search in Google Scholar
[
Lampe, K., M. Mäkelä, M. V. Garrido, H. Anttila, I. Autti-Rämö, N. J. Hicks and A. Malmivaara. 2009. “The HTA Core Model: A Novel Method for Producing and Reporting Health Technology Assessments.” International Journal of Technology Assessment in Health Care 25(S2), 9 – 20.
]Search in Google Scholar
[
Lawson, C. and J. Nemec. 1998. “Central European Health Reform: The Case of Slovakia, 1990 – 97.” Journal of European Social Policy 8(3), 237 – 252.
]Search in Google Scholar
[
Medveď, J., J. Nemec and L. Vítek. 2005. “Social Health Insurance and its Failures in the Czech Republic and Slovakia: The Role of the State.” Prague Economic Papers 14(1).10.18267/j.pep.253
]Search in Google Scholar
[
Ministry of Health (MoH). 2013. Hodnocení zdravotnických technologií: Tvorba metodických postupů a realizace zkušebního hodnocení (seminář 21. 6. 2013). Available at https://www.mzcr.cz/obsah/novinky_114_129_1.html (last accessed 6 July 2020).
]Search in Google Scholar
[
Ministry of Health (MoH). 2018. Order of the Minister of Health of the Republic No. 25, dated 10 April 2018: Statute and Rules of Procedure of the Committee, Order No. č.25 / 2019. Available at https://www.mzcr.cz/prikaz-ministrac-25-2019-statut-a-jednaci-rad-komise/
]Search in Google Scholar
[
Ministry of Health (MoH). 2018 Ministerstvo připravilo nová pravidla pro rozhodování Přístrojové komise.
]Search in Google Scholar
[
(2018, April 11). Retrieved from http://www.mzcr.cz/dokumenty/ministerstvo-pripravilo-nova-pravidla-pro-rozhodovani-pristrojove-komise_15265_3801_1.html
]Search in Google Scholar
[
Ministry of Health (MoH). 2018. O přístrojové komisi. Praha: Ministerstvo zdravotnictví ČR. Available at https://www.mzcr.cz/o-pristrojove-komisi/ (last accessed 19 September 2020).
]Search in Google Scholar
[
Ministry of Health (MoH). 2019. Hodnocení vývoje systému veřejného zdravotního pojištění v roce 2019. Praha: Ministerstvo zdravotnictví ČR. Available at https://www.psp.cz/sqw/text/tiskt.sqw?O=8&CT=1050&CT1=0 (last accessed 19 January 2021).
]Search in Google Scholar
[
Mueller, D., D. Tivey and D. Croce. 2017. “Health-Technology Assessment: Its Role in Strengthening Health Systems in Developing Countries.” Strengthening Health Systems 2(1), 6 – 11.
]Search in Google Scholar
[
Nemec, J., M. Kubák, G. Donin and Z. Kotherová. 2021. “Efficiency of Public Procurement in the Czech and Slovak Health Care Sectors.” Transylvanian Review of Administrative Sciences 17(62), 115 – 133.
]Search in Google Scholar
[
Nemec, J., D. Spacek and M. de Vries. 2015. “Coordinating Healthcare under a Pluralistic Health Insurance System: The Case of Slovakia.” Transylvanian Review of Administrative Sciences 11(45), 168 – 184.
]Search in Google Scholar
[
OECD. Health expenditure and financing. 2020. In: OECD. Stat. Available at: https://stats.oecd.org/Index.aspx?DataSetCode=SHA/ (last accessed January 2021).
]Search in Google Scholar
[
Office of Technology Assessment. 1978. Policy implications of the computed tomography (CT) scanner. Washington DC: U.S. Government Printing Office.
]Search in Google Scholar
[
Peter, L., L. Hajek, P. Maresova, M. Augustynek and M. Penhaker. 2020. “Medical Devices: Regulation, Risk Classification, and Open Innovation.” Journal of Open Innovation: Technology, Market, and Complexity 6(2), 42.
]Search in Google Scholar
[
Ramsay C. R., A. M. Grant, S. A. Wallace et al. 2001. “Statistical Assessment of the Learning Curves of Health Technologies.” Health Technol Assess 5(12), 1 – 79.
]Search in Google Scholar
[
Rosina et al. 2009.
]Search in Google Scholar
[
Siebert, M., L. C. Clauss, M. Carlisle, B. Casteels, P. De Jong, M. Kreuzer and A. W. Lang. 2002. “Health Technology Assessment for Medical Devices in Europe.” International Journal of Technology Assessment in Health Care 18(3), 733 – 740.
]Search in Google Scholar
[
Sorenson, C., M. Drummond and B. B. Khan. 2013. “Medical Technology as a Key Driver of Rising Health Expenditure: Disentangling the Relationship.” ClinicoEconomics and Outcomes Research: CEOR 5, 223.
]Search in Google Scholar
[
Tarricone, R., G. Callea, M. Ogorevc and V. Prevolnik Rupel. 2017. “Improving the Methods for the Economic Evaluation of Medical Devices.” Health Economics 26(S1), 70 – 92.
]Search in Google Scholar
[
Tarricone, R., A. Torbica, F. Ferre and M. Drummond. 2014. “Generating Appropriate Clinical Data for Value Assessment of Medical Devices: What Role does Regulation Play ?” Expert Review of Pharmacoeconomics & Outcomes Research 14(5), 707 – 718.
]Search in Google Scholar
[
Taylor, R. S. and C. P. Iglesias. 2009. “Assessing the Clinical and Cost-Effectiveness of Medical Devices and Drugs: Are they that Different ?” Value in Health 12(4), 404 – 406.
]Search in Google Scholar
[
Vitezić, N., S. S. Cankar and Ž. Linšak. 2019. “Effectiveness Measurement Using DEA & BSC Methods in Public Health Services.” NISPAcee Journal of Public Administration and Policy 12(1), 199 – 216.
]Search in Google Scholar
[
Vlada.cz. 2018. “Programové Prohlášení Vlády.” Vláda ČR. Available at https://www.vlada.cz/cz/jednani-vlady/programove-prohlaseni/programove-prohlaseni-vlady-165960/ (last accessed 6 June 2020).
]Search in Google Scholar
[
World Health Organization. 2017. Medical Device: WHO. Available at https://www.who.int/medical_devices/full_deffinition/en/ (last accessed 11 September, 2020).
]Search in Google Scholar
